Candida

Ammoniac, Aspergillus Niger Var. Niger, Caffeic Acid, Candida Albicans, Candida Parapsilosis, Ipecac, Lycopodium Clavatum Spore, Yeast Mannan, Vaccinium Vitis-idaea Leaf

Viatrexx Bio Incorporated
Human Otc Drug
NDC 63776-073

Candida also known as Ammoniac, Aspergillus Niger Var. Niger, Caffeic Acid, Candida Albicans, Candida Parapsilosis, Ipecac, Lycopodium Clavatum Spore, Yeast Mannan, Vaccinium Vitis-idaea Leaf is a human otc drug labeled by 'Viatrexx Bio Incorporated'. National Drug Code (NDC) number for Candida is 63776-073. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Candida drug includes Ammoniac - 200 [kp_C]/mL Aspergillus Niger Var. Niger - 200 [kp_C]/mL Caffeic Acid - 200 [kp_C]/mL Candida Albicans - 200 [kp_C]/mL Candida Parapsilosis - 200 [kp_C]/mL Ipecac - 200 [kp_C]/mL Lycopodium Clavatum Spore - 200 [kp_C]/mL Vaccinium Vitis-idaea Leaf - 200 [kp_C]/mL Yeast Mannan - 200 [kp_C]/mL . The currest status of Candida drug is Active.

Drug Information:

Drug NDC:	63776-073
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Candida
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Ammoniac, Aspergillus Niger Var. Niger, Caffeic Acid, Candida Albicans, Candida Parapsilosis, Ipecac, Lycopodium Clavatum Spore, Yeast Mannan, Vaccinium Vitis-idaea Leaf
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Viatrexx Bio Incorporated
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Spray
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	AMMONIAC - 200 [kp_C]/mL ASPERGILLUS NIGER VAR. NIGER - 200 [kp_C]/mL CAFFEIC ACID - 200 [kp_C]/mL CANDIDA ALBICANS - 200 [kp_C]/mL CANDIDA PARAPSILOSIS - 200 [kp_C]/mL IPECAC - 200 [kp_C]/mL LYCOPODIUM CLAVATUM SPORE - 200 [kp_C]/mL VACCINIUM VITIS-IDAEA LEAF - 200 [kp_C]/mL YEAST MANNAN - 200 [kp_C]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	24 Jul, 2012
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	25 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	VIATREXX BIO INCORPORATED
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
NUI:	N0000185372 N0000175629 N0000184306 N0000185001 M0008890 M0000728
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	8471AK50P8 9IOA40ANG6 U2S3A33KVM 4D7G21HDBC 0KZ676D44N 62I3C8233L C88X29Y479 FO2ACM0RMQ 91R887N59P
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:	Non-Standardized Fungal Allergenic Extract [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:	Increased Histamine Release [PE] Cell-mediated Immunity [PE] Increased IgG Production [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:	Fungal Proteins [CS] Allergens [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:	Allergens [CS] Cell-mediated Immunity [PE] Fungal Proteins [CS] Increased Histamine Release [PE] Increased IgG Production [PE] Non-Standardized Fungal Allergenic Extract [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
63776-073-15	1 BOTTLE, SPRAY in 1 BOX (63776-073-15) / 50 mL in 1 BOTTLE, SPRAY	24 Jul, 2012	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Candida

Ammoniac & more..

Spray
VIATREXX BIO INCORPORATED
NDC: 63776-073

Purpose:

Purpose: ammoniacum gummi anti-age aspergillus niger urogenital drainage caffeic acid urogenital drainage candida albicans dysbiosis candida parapsilosis dysbiosis ipecacuanha drainage lycopodium clavatum drainage mannan drainage vaccinium vitis idaea intestinal vaccinium vitis idaea intestinal

Product Elements:

Candida ammoniac, aspergillus niger var. niger, caffeic acid, candida albicans, candida parapsilosis, ipecac, lycopodium clavatum spore, yeast mannan, vaccinium vitis-idaea leaf alcohol water ammoniac ammoniac aspergillus niger var. niger aspergillus niger var. niger caffeic acid caffeic acid candida albicans candida albicans candida parapsilosis candida parapsilosis ipecac ipecac lycopodium clavatum spore lycopodium clavatum spore yeast mannan yeast mannan vaccinium vitis-idaea leaf vaccinium vitis-idaea leaf

Indications and Usage:

Uses for the relief of symptoms due to candida, including precursors and byproducts

Warnings:

Warnings stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. if pregnant or breastfeeding, ask a health care practitioner before use.

Dosage and Administration:

Dosage 1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.

Package Label Principal Display Panel:

Principal display panel item: vpc0070 ndc 63776-073-15 homeopathic remedy candida + â¢ for the relief of symptoms due to candida, including precursors and byproducts oral spray 50ml 1.7 oz viatrexx â¢ bio incorporated manufactured by viatrexx www.viatrexx.com newark, de 19713 candida + 50 ml 1.7 oz viatrexx â¢ bio incorporated item: vpc0070 ndc: 63776-073-15 indications: for the relief of symptoms due to candida, including precursors and byproducts directions: 1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner. mfg. for viatrexx bio incorporated. www.viatrexx.com newark, de 19713 carton label

Further Questions:

Questions info@viatrexx.com

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.